GENOPTIX INC (NASDAQ: GXDX)





$31.34 0.09 (0.29%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
38.13
52-Week Low Price
24.15
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.54 B
P/E Ratio (TTM)
19.5
Diluted EPS (TTM)
1.63
Shares
17.17 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -9% - GXDX has underperformed the S&P 500 by 35%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
QUEST DIAGNOSTICS INC (DGX) $55.68 -  $0.68(1.24%)10.28 B
LABORATORY CP AM HLDGS (LH) $70.15 -  $0.01(0.01%)7.50 B
BIO-REFERENCE LABS INC (BRLI) $38.35 -  $0.40(1.05%)0.53 B
GENOMIC HEALTH INC (GHDX) $17.18 -  $0.24(1.42%)0.48 B
ENZO BIOCHEM INC (ENZ) $4.81 -  $0.05(1.05%)0.18 B
CLARIENT INC (CLRT) $2.16 -  $0.02(0.92%)0.18 B
RADNET INC (RDNT) $2.35 -  $0.10(4.44%)0.08 B
MEDTOX SCIENTIFIC INC (MTOX) $8.48 -  $0.13(1.56%)0.07 B
BIOCLINICA INC (BIOC) $4.46 -  $0.00(0.00%)0.06 B
CORD BLOOD AMERICA INC (CBAI) $0.01 -  $0.00(12.22%)0.04 B
STOCK ANALYSIS
There are currently no Stock Analysis.
GXDX RELATED HEADLINES
arrow
Healthcare Stocks Galore
<ul> <li>Clarient's breast cancer technology for treatment</li> <li>Biomeds brain cancer drug in Phase III</li> <li>Medarexs 6 clinical candidates for '09 and '10</li> </ul>

Wall Street Media 12/11/2008
arrow
William Blair & Company Initiates Coverage of Genoptix, Inc. With Market Perform Rating
William Blair & Company Initiates Coverage of Genoptix, Inc. With Market Perform Rating

At BusinessWire 11/25/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2